Reporting bias in retrospective ascertainment of drug-induced embryopathy

Lancet

Volumn 354, Issue 9191, 1999, Pages 1700-1701

  Bar Oz, Benjamin ^a   Moretti, Myla E ^a   Mareels, Guy ^b   Van Tittelboom, Tony ^b   Koren, Gideon ^a  

^a Division of Clinical Pharmacology and Toxicology   (Canada)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ARTICLE; CONGENITAL MALFORMATION; DATA ANALYSIS; EPIDEMIOLOGY; FEMALE; FETUS; HUMAN; NEWBORN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION;

EID: 0033552390     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04411-6     Document Type: Article

References (4)

1. Koren G., Pastuszak A., Ito S. Drugs in pregnancy. N Engl J Med. 338:1998;1128-1137.
2. Koren G., Graham K., Feigenbaum A., Einarson T. Evaluation and counseling of teratogenic risk: the motherisk approach. J Clin Pharmacol. 33:1993;405-411.
3. Koren G., Bologa M., Long D., Feldman Y., Shear N.H. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol. 160:1989;1190-1194.
4. Koren G., Gladstone D., Robeson C., Robieux I. The perception of teratogenic risk of cocaine. Teratology. 46:1992;567-571.